Category:

Non-Life

Latest

SAT rejects IRDA order, allows sale of pledged Reliance General insurance shares

Rejecting the  IRDA’s Dec 27 order, the SAT in its order on Thursday has asked the IDBI Trusteeship Services, that is holding the pledged shares as a custodian, to make every endevour to find a suitable buyer for the pleged shares.

“ As and when a suitable buyer is found suitable application would be made before IRDAI for appropriate approval to enable the IRDAI to carry out due diligence and to ascertain fulfillment of Fit and Proper criteria, financial soundness,’’ said the SAT order .

read more

US expands its reinsurance program,transfers $400 mn in flood risk to capital markets

As part of the agreement, FEMA will pay $50.28 million in premiums for the first year of reinsurance coverage. Additionally, the agreement will cover 3.33 percent of losses for any single flood event with losses between $6 and $9 billion, and 30 percent if that same flood event has losses that rise to $9 to $10 billion.
 

read more

Berkshire Hathaway 100% ready for my departure: Warren Buffett

-Along with Microsoft co-founder Bill Gates and his wife Melinda Gates, Buffett in 2010 launched the “Giving Pledge,” in which billionaires promise to give at least half their wealth to philanthropic causes,
=Berkshire Hathaway has holdings in companies including American Express, JPMorgan Chase and Goldman Sachs. It is also active in sectors like insurance, through Geico; rail, with BNSF; and energy, via PacifiCorp,
-Forbes said in its rankings last year that Buffett was worth $82.5 billion.

read more

China ends 2yr state custody of troubled Anbang Insurance

Authorities took control of the 2 trillion yuan ($285 billion) conglomerate in February 2018 after its former chairman Wu Xiaohui was arrested — and subsequently jailed — for fundraising fraud. They initially set themselves a 12-month timeline to raise cash by jettisoning non-core assets such as luxury hotels, preserve Anbang’s main insurance operations and find strategic investors. That deadline was later extended by a year to Feb. 22.

read more

How pharma firms are using Blockchain to track down counterfeit drugs

-“The current point-to-point systems infrastructure lacks the ability to keep data in sync across the healthcare supply chain, which ultimately increases the risk of counterfeit, diverted or otherwise illegitimate products,” David Vershure, head of channel and contract management for Roche’s Genentech unit, said in a statement.
-Among the 24 participating companies are Amgen Inc., FedEx Corp., GlaxoSmithKline Plc, Novartis, AmerisourceBergen Corp., Sanofi, Walgreens Boots Alliance Inc. and Walmart Inc.

-The World Health Organization estimates that counterfeit medicines worth 73 billion euros ($79.26 billion) are traded annually.

read more